Valery Feigin, MD, PhD, FRSNZ, FRAS, FAAN


Current position: Professor of Epidemiology and Neurology, Director of the National Institute for Stroke and Applied Neurosciences (NISAN), School of Public Health and Psychosocial Studies, Faculty of Health and Environmental Sciences, AUT University, Auckland, New Zealand.

Fellow of the Royal Society of New Zealand; Fellow of the Russian Academy of Sciences. 

SCOPUS Citation Output: h-index 102, number of citations >117,000 (as of March 2022)

PBRF 'A' rating in 2006, 2012, 2018

Twitter: @FeiginValery

Valery's papers are currently ranked by Web of Science Clarivate Analytics in the top 1% worldwide, by citations.

Medical and Research Background:

Valery is a certified neurologist and clinical epidemiologist. He graduated in medicine from the State Medical School of Novosibirsk, Russia and undertook advanced training in neurology and clinical epidemiology. He holds a PhD from the Institute of Neurology, Moscow, Russia;  an MSc from Novosibirsk State Medical Institute, Russia and an MSc in Clinical Epidemiology from Erasmus University, Rotterdam, the Netherlands.

Research Projects:

Valery has contributed to the design and performance of a number of national and international research projects  including:

  • RIBURST study (Reducing the International Burden of Stroke using Mobile Technology)
  • MARS study (Effectiveness of the Stroke Riskometer Pro App / Mobile Apps to Reduce Stroke)
  • The WHO MONICA project
  • Freemasons Health study
  • Auckland Regional Community Stroke (ARCOS) study
  • Traumatic brain injury burden in New Zealand: A population-based incidence & outcomes study (BIONIC and BIONIC4You studies)
  • The Neuroprotection Involving Cooling Evaluation in Stroke study (NICE)
  • Asian Pacific Cohort Studies Collaboration (APCSC)
  • POLYPILL Recruitment pilot study
  • Auckland Stroke Outcomes (ASTRO) study
  • Stroke Attention Rehabilitation Trial (START)
  • Goals and Self Regulation Skills in Brain Injury Rehabilitation
  • POLYPILL IMPACT (Improving Adherence using Combination Therapy) trial projects
  • Disabled by Illness or Injury Study: Does it Matter? study

Journal Editor and Editorial Board member:

  • 2008-present - Editor-in-Chief of Neuroepidemiology
  • 2018-2019 - Journal of Stroke Medicine
  • 2015-2019 - Journal of Neurorestoratology
  • 2014-2018 - American Journal of Trauma and Treatment
  • 2014-2017 - Neurology, Neuropsychiatry, Psychosomatics
  • 2012-2016 - Cerebrovascular Disease
  • 2012-2018 - European Medical Journal - Neurology
  • 2011-2018 - World Journal of Methodology
  • 2011-2018 - World Journal of Neurology
  • 2011-2016 - Journal of Geriatric Cardiology
  • 2010-present - Topics in Stroke Rehabilitation
  • 2009-2017 - Stroke Research and Treatment
  • 2007-2008 - Stroke
  • 2005-2018 - Acta Clinica Croatica
  • 1999-2017 - European Journal of Neurology
  • 1997-2002 - The Pain and its treatment

Professional Affiliations:

  • 2019-present: Medical Director, Stroke Central Region, Inc.
  • 2018-2023: Visiting Professor, Capital Medical University (CMU), Beijing, China
  • 2014-present: Affiliate Professor, Department of Global Health, University of Washington, USA
  • 2003-present: Honorary Professor, Novosibirsk State Medical Academy, Russia
  • 2000-present: Professor of Neurology, Russian Academy of Medical Sciences, Russia

Membership in Professional Societies and other activities:

Valery is a member of numerous professional societies and committees, including:

  • 2019-present: World Stroke Organization, Fellow
  • 2018-present: World Stroke Organization, Executive Committee member
  • 2018-present: International Institute for Brain Health, Croatia, International Advisory Board member
  • 2015-present: National Science Challenge - Ageing Well Science Leadership Team
  • 2014-present:  Brain Research New Zealand, Centre of Research Excellence (CoRE), Ministry of Business, Innovation & Employment
  • Founding member of the Scientist Panel on Neuroepidemiology
  • Task Force on Teaching of Clinical Epidemiology of the European Federation of Neurological Societies
  • Faculty member of Educational Activities in Eastern Europe of the European Federation of Neurological Societies
  • 2011-present: World Stroke Organization (Board of Directors 2012-2020)
  • 2013-present: World Stroke Organization Stroke Guidelines and Quality Committee
  • 2010-present: INTERSTROKE Study, Steering Committee member
  • 2010-present: Neurology Association of New Zealand
  • 2010-present: Northern Region Stroke Network
  • 2009-present: American Academy of Neurology, Neuroepidemiology section
  • 2007-2009: World Federation for NeuroRehabilitation, Management Committee member
  • 2006-2008: World Stroke Organization, Chair of the Membership Committee
  • 2002-present: Stroke Society of Australasia, Fellow
  • 1998-2000: European Neurological Society, Fellow
  • 1997- present: American Academy of Neurology, Fellow
  • 1996-2005: European Federation of Neurological Societies, Chair of the Task Force
  • 1997-1999: European Society for Clinical Neuropharmacology, Advisory Board member
  • 1995-present: Mayo Alumni Association, Fellow
  • 1992-2002: Stroke Council of the American Heart Association, Fellow
  • 1989-2006: International Stroke Society, Fellow

Publications, Awards, Honours:

Valery has authored and/or co-authored:

  • More than 650 scientific publications on stroke epidemiology, prevention and management, including 12 handbooks and 358 journal articles (of which more than 75 in The Lancet)
  • A number of book chapters and Cochrane systematic reviews
  • Guidelines for physicians

Valery is the recipient of a number of prestigious national and international awards and distinctions, including:

  • 2018: SSA Excellence in Stroke Award for 2018. Awarded by the Stroke Society of Australasia
  • 2016: Health Research Council of New Zealand “Research Excellence” award for outstanding research
  • 2015: The Royal Society of New Zealand’s MacDiarmid Medal, for outstanding research in stroke epidemiology and prevention worldwide, and the development of ground-breaking technology in primary stroke prevention
  • 2014: The World Stroke Organization President’s Award for contributions to clinical stroke research
  • 2001: Gedeon Richter Award for studies on Cavinton in acute stroke
  • 1998: Bruce Shoenburg International Award and Lecturer in Neuroepidemiology (American Academy of Neurology)
  • 1991: Fogarty International Centre Research Grant Award (National Institute of Neurological Disorders & Stroke of the USA), Mayo Clinic, USA

Research Interests:

  • Cerebrovascular disorders (incidence, prevalence, risk factors, outcomes, prognosis, treatment, rehabilitation, health care organisation), dementia (incidence, prevalence, determinants, prevention and management)
  • Traumatic brain injury (incidence, prevalence, prevention, rehabilitation and health care organisation)
  • Clinical epidemiology (especially surveys, case-control studies, cohort studies and randomised controlled clinical trials)
  • Public health (especially in relation to neurological disorders and traumatic brain injury) and neuropsychology

Areas of particular expertise are:

  • Stroke and Traumatic Brain Injury prevention
  • Epidemiology and treatment/rehabilitation
  • Neuroepidemiology


As well as attending and presenting at numerous conferences, Valery is Chairman and Founder of:

  • The International Congress on Clinical Neurology and Epidemiology (ICNE)
  • The New Zealand Applied Neurosciences Conference (NZANC)

Peer-reviewed journal articles: (Current year and immediately preceding year only)


Saywell, N. L., Vandal, A. C., Mudge, S., Hale, L., Brown, P., Feigin, V., . . . Taylor, D. (2020). Telerehabilitation after stroke using readily available technology: A randomized controlled trial. Neurorehabilitation and Neural Repair. doi:10.1177/1545968320971765

Jacob, L., Cogné, M., Tenovuo, O., Røe, C., Andelic, N., Majdan, M., . . . Jarrett, M. (with Feigin, V.L., Jones, K., & Theadom, A. as CENTER-TBI participants and Investigators)(2020). Predictors of access to rehabilitation in the year following traumatic brain injury: A European prospective and multicenter study. Neurorehabilitation and Neural Repair, 34(9), 814-830. doi:10.1177/1545968320946038

Marquez-Romero, J. M., Romo-Martínez, J., Calleja-Castillo, J. M., Espinoza-Casillas, C., Prado-Aguilar, C. A., & Feigin, V. (2020). Stroke terminology in Mexico: Consensus using the Delphi method. Revista Mexicana de Neurociencia, 21(5), 187-191. doi:10.24875/rmn.20000015

Feigin, V. L., Vos, T., Alahdab, F., Amit, A. M. L., Bärnighausen, T. W., Beghi, E., . . . Murray, C. J. L. (2020). Burden of neurological disorders across the US from 1990-2017. JAMA Neurology. doi:10.1001/jamaneurol.2020.4152

Liu, L., Feigin, V., Sacco, R. L., & Koroshetz, W. J. (2020). Promoting global collaboration for brain health research. BMJ, 371, m3753. doi:10.1136/bmj.m3753

Deuschl, G., Beghi, E., Fazekas, F., Varga, T., Christoforidi, K. A., Sipido, E., . . . Feigin, V. L. (2020). The burden of neurological diseases in Europe: An analysis for the Global Burden of Disease Study 2017. The Lancet Public Health, 5(10), e551-e567. doi:10.1016/s2468-2667(20)30190-0

Feigin, V., & GBD 2019 Viewpoint Collaborators. (2020). Five insights from the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1135-1159. doi:10.1016/S0140-6736(20)31404-5

Wang, H., Abbas, K. M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Feigin, V.L. et. al. (2020). Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1160-1203. doi:10.1016/s0140-6736(20)30977-6

Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Feigin, V.L. et. al. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204-1222. doi:10.1016/s0140-6736(20)30925-9

Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Feigin, V.L. et. al. (2020). Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1223-1249. doi:10.1016/s0140-6736(20)30752-2

Lozano, R., Fullman, N., Mumford, J. E., Knight, M., Barthelemy, C. M., Feigin, V.L. et al. (2020). Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1250-1284. doi:10.1016/S0140-6736(20)30750-9

Wiens, K. E., Lindstedt, P. A., Blacker, B. F., Johnson, K. B., Baumann, M. M., Feigin, V.L. et. al. (2020). Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17. The Lancet Global Health, 8(8), e1038-e1060. doi:10.1016/S2214-109X(20)30230-8

Deshpande, A., Miller-Petrie, M. K., Lindstedt, P. A., Baumann, M. M., Johnson, K. B., Feigin, V.L. et. al. (2020). The global distribution of lymphatic filariasis, 2000–18: A geospatial analysis. The Lancet Global Health, 8(9), e1186-e1194. doi:10.1016/S2214-109X(20)30286-2

Gravesteijn, B. Y., Sewalt, C. A., Nieboer, D., Menon, D. K., Maas, A., Feigin, V.L. et. al. (2020). Tracheal intubation in traumatic brain injury: A multicentre prospective observational study. British Journal of Anaesthesia. doi:10.1016/j.bja.2020.05.067

Wiens, K. E., Lindstedt, P. A., Blacker, B. F., Johnson, K. B., Baumann, M. M., Feigin, V.L. et. al. (2020). Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17. The Lancet Global Health, 8(8), e1038-e1060. doi:10.1016/S2214-109X(20)30230-8

Krishnamurthi, R., George, A., Merkin, A., Bhattacharjee, R., & Feigin, V. L. (2020). Can we stop the stroke tsunami? Mitigating the barriers, amplifying the facilitators. Journal of the Royal Society of New Zealand, 1-20. doi:10.1080/03036758.2020.1798477

Andelic, N., Røe, C., Brunborg, C., Zeldovich, M., Løvstad, M., Feigin, V.L. et. al. (2020). Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: Results from the CENTER-TBI study. Journal of Neurology. doi:10.1007/s00415-020-10022-2

Voormolen, D. C., Polinder, S., von Steinbuechel, N., Feng, Y., Wilson, L., Feigin, V.L. et. al. (2020). Health-related quality of life after traumatic brain injury: Deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom. Quality of Life Research. doi:10.1007/s11136-020-02583-6

Beghi, E., Feigin, V., Caso, V., Santalucia, P., & Logroscino, G. (2020). COVID-19 infection and neurological complications: Present findings and future predictions. Neuroepidemiology, 1-6. doi:10.1159/000508991

Feigin, V.L., Jones, K., Theadom, A. and the CENTER-TBI investigators and participants (2020). Informed consent procedures in patients with an acute inability to provide informed consent: Policy and practice in the CENTER-TBI study. Journal of Critical Care, 59, 6-15. doi:10.1016/j.jcrc.2020.05.004

Wiebers, D. O., & Feigin, V. (2020). What the COVID-19 crisis is telling humanity [editorial]. Neuropepidemiology, 54. doi:10.1159/000508654

Feigin, V.L., Jones, K., Theadom, A. and the CENTER-TBI investigators and participants (2020). How do 66 European institutional review boards approve one protocol for an international prospective observational study on traumatic brain injury? Experiences from the CENTER-TBI study. BMC Medical Ethics, 21(1), 36. doi:10.1186/s12910-020-00480-8

Brainin, M., Feigin, V.L., Norrving, B., Martins, S., Hankey, G., Hachinski, V. (on behalf of the WSO Board of Directors) (2020).  Global prevention of stroke and dementia: The WSO Declaration. The Lancet Neurology, 19, 487-488.

Feigin, V., Jones, K., Theadom, A., et. al. (2020). Machine learning algorithms performed no better than regression models for prognostication in traumatic brain injury. Journal of Clinical Epidemiology, 122, 95-107. doi:10.1016/j.jclinepi.2020.03.005

Kim, J., Thayabaranathan, T., Donnan, G. A., Howard, G., Howard, V. J., Rothwell, P. M., Feigin, V.L., . . . Thrift, A. G. (2020). Global stroke statistics 2019. International Journal of Stroke. doi:10.1177/1747493020909545

Krishnamurthi, R. V., Ikeda, T., & Feigin, V. L. (2020). Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: A systematic analysis of the Global Burden of Disease Study 2017. Neuroepidemiology. doi:10.1159/000506396

Feigin, V. L., Brainin, M., Norrving, B., Gorelick, P. B., Dichgans, M., Wang, W., . . . Hankey, G. J. (2020). What is the best mix of population‐wide and high‐risk targeted strategies of primary stroke and cardiovascular disease prevention?. Journal of the American Heart Association, 9(3). doi:10.1161/jaha.119.014494

Theadom, A., Mahon, S., Hume, P., Starkey, N., Barker-Collo, S., Jones, K., Majdan, M. & Feigin, V. L. (2020). Incidence of sports-related Traumatic Brain Injury of all severities: A systematic review. Neuroepidemiology. doi:10.1159/000505424

Barker-Collo, S., Theadom, A., Jones, K., Starkey, N., Fernando, K., Kahan, M., . . . Feigin, V. (2020). Three methods for examining trajectories in neuropsychological performance across the first 4 years after mild Traumatic Brain Injury. Brain Impairment. doi:10.1017/BrImp.2019.31

Krishnamurthi, R.V., Barker-Collo, S., Barber, P.A., Tippett, L.J., Dalrymple-Alford, J.C., Tunnage, B., Mahon, S., Parmar, P.G., Moylan, M. & Feigin, V.L. (2020). Community knowledge and awareness of stroke in New Zealand. Journal of Stroke and Cerebrovascular Diseases. doi:

Merkin, A. G., Medvedev, O. N., Sachdev, P. S., Tippett, L., Krishnamurthi, R., Mahon, S., Kasabov, N., Parmar, P., . . . Feigin, V. L. (2020). New avenue for the Geriatric Depression Scale: Rasch transformation enhances reliability of assessment. Journal of Affective Disorders, 264, 7-14. doi:10.1016/j.jad.2019.11.100

Mahon, S., Faulkner, J., Barker-Collo, S., Krishnamurthi, R., Jones, K., & Feigin, V. (2019). Slowed information processing speed at four years poststroke: Evidence and predictors from a population-based follow-up study. Journal of Stroke and Cerebrovascular Diseases. doi:10.1016/j.jstrokecerebrovasdis.2019.104513


Feigin, V., Vos, T., Nichols, E., Owolabi, M., Carroll, W. M., Dichgans, M., Deuschl, G., Parmar, P., Brainin, M. & Murray, C. (2019). The global burden of neurological disorders: Translating evidence into policy. The Lancet Neurology. doi:10.1016/S1474-4422(19)30411-9

Zhang, X., Wang, A., Zhang, J., Singh, M., Liu, D., Zuo, Y., Wu, L., Song, M., Wang, W., Feigin, V.L., Wang, Y. & Zheng, D. (2019). Association of plasma C-reactive protein with ischemic stroke: A Mendelian randomization study. European Journal of Neurology. doi:10.1111/ene.14113

Feigin, V., & Brainin, M. (2019). Reducing the burden of stroke: Opportunities and mechanisms [invited editorial]. International Journal of Stroke, 14(8), 761-762. doi:10.1177/1747493019874718

Lindsay, M. P., Norrving, B., Sacco, R. L., Brainin, M., Hacke, W., Martins, S., . . . Feigin, V. (2019). World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. International Journal of Stroke, 14(8), 806-817. doi:10.1177/1747493019881353

Feigin, V. L., Krishnamurthi, R., Barker-Collo, S., Barber, P. A., Rathnasabapathy, Y., Te Ao, B., . . . Douwes, J. (2019). Measuring stroke and transient ischemic attack burden in New Zealand: Protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V). International Journal of Stroke. doi:10.1177/1747493019884528

Jones, K., Theadom, A., Prah, P., Starkey, N., Barker-Collo, S., Ameratunga, S., & Feigin, V. L. (2019). Changes over time in family members of adults with mild traumatic brain injury. Brain Impairment, doi:10.1017/brimp.2019.27

Barker-Collo, S., Krishnamurthi, R., Theadom, A., Jones, K., Starkey, N., & Feigin, V. (2019). Incidence of stroke and traumatic brain injury in New Zealand: Contrasting the BIONIC and ARCOS-IV studies. New Zealand Medical Journal, 132(1502), 40-54.

Feigin, V. (as a member of the CENTER-TBI Participants and Investigators (2019). Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. The Lancet Neurology, 18(10), 923-934. doi:10.1016/s1474-4422(19)30232-7

Brainin, M., Feigin, V., Bath, P. M., Collantes, E., Martins, S., Pandian, J., . . . Teuschl, Y. (2019). Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization. International Journal of Stroke. doi:10.1177/1747493019873706

Phan, H. T., Blizzard, C. L., Reeves, M. J., Thrift, A. G., Cadilhac, D. A., Sturm, J., . . . Gall, S. (2019). Sex differences in long-term quality of life among survivors after stroke in the INSTRUCT. Stroke. doi:10.1161/STROKEAHA.118.024437

Bergin, P. S., Brockington, A., Jayabal, J., Scott, S., Litchfield, R., Roberts, L., . . . Parmar, P., Feigin, V. (2019). Status epilepticus in Auckland, New Zealand: Incidence, etiology, and outcomes. Epilepsia, 60, 1552-1564. doi:10.1111/epi.16277

Jones, K. M., Prah, P., Starkey, N., Theadom, A., Barker-Collo, S., Ameratunga, S., Feigin, V.L. . . . BIONIC Study Group. (2019). Longitudinal patterns of behavior, cognition, and quality of life after mild traumatic brain injury in children: BIONIC study findings. Brain Injury, 1-10. doi:10.1080/02699052.2019.1606445

Vosoughi, K., Stovner, L. J., Steiner, T. J., Moradi-Lakeh, M., Fereshtehnejad, S. -M., Farzadfar, F., . . . Murray, C. J. L. (2019). The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: Findings from the Global Burden of Disease study 2016. Journal of Headache and Pain, 20(1), 40. doi:10.1186/s10194-019-0990-3

Fereshtehnejad, S. -M., Vosoughi, K., Heydarpour, P., Sepanlou, S. G., Farzadfar, F., Tehrani-Banihashemi, A., . . . Moradi-Lakeh, M. (2019). Burden of neurodegenerative diseases in the Eastern Mediterranean region, 1990-2016: Findings from the Global Burden of Disease 2016 Study. European Journal of Neurology, 26, 1252-1265. doi:10.1111/ene.13972

Martins, S. C., Sacks, C., Feigin, V., & et. al. (2019). Priorities to reduce the burden of stroke in Latin American countries. The Lancet Neurology. doi:10.1016/S1474-4422(19)30068-7

Feigin, V., & GBD 2017 Diet Collaborators. (2019). Health effects of dietary risks in 195 countries, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. doi:10.1016/S0140-6736(19)30041-8

Theadom, A., McDonald, S., Starkey, N., Barker-Collo, S., Jones, K., Ameratunga, S., . . . Feigin, V. (2019). Social cognition four years after mild-TBI: An age-matched prospective longitudinal cohort study. Neuropsychology. doi:10.1037/neu0000516

Barker-Collo, S., Theadom, A., Starkey, N. J., Kahan, M., Jones, K., & Feigin, V. (2019). Long-term factor structure of the Rivermead Post-Concussion Symptom Questionnaire in mild traumatic brain injury and normative sample. Brain Injury, 33(5), 618-622. doi:10.1080/02699052.2019.1570339

Feigin, V., & GBD 2016 Neurology Collaborators. (2019). Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease study 2016. The Lancet Neurology, 18(5), 459-480. doi:10.1016/S1474-4422(18)30499-X

Feigin, V., & GBD 2016 Stroke Collaborators. (2019). Global, regional, and national burden of stroke, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. doi:10.1016/S1474-4422(19)30030-4

Feigin, V., & GBD 2016 Brain and other CNS Cancer Collaborators. (2019). Global, regional, and national burden of brain and other CNS cancer, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(4), 376-393. doi:10.1016/S1474-4422(18)30468-x

Feigin, V., & GBD 2016 Epilepsy Collaborators. (2019). Global, regional, and national burden of epilepsy, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(4), 357-375. doi:10.1016/S1474-4422(18)30454-x

Feigin. V.L. and the ESO ESMINT EAN SAFEurvey on Stroke Collaborators (2019). Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal, 4(1), 13-28. doi: 10.1177/2396987318786023

Feigin, V. (2019). Anthology of stroke epidemiology in the 20th and 21st centuries: Assessing the past, the present, and envisioning the future. International Journal of Stroke. doi:10.1177/1747493019832996

Feigin, V., & GBD 2016 Multiple Sclerosis Collaborators. (2019). Global, regional, and national burden of multiple sclerosis 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(3), 269-285. doi:10.1016/S1474-4422(18)30443-5

Feigin, V.L. et. al. (CENTER-TBI Investigators and Participants) (2019). Variation in neurosurgical management of traumatic brain injury: A survey in 68 centers participating in the CENTER-TBI study. Acta Neurochirurgica. doi:10.1007/s00701-018-3761-z

Feigin, V.L., et. al. (2019). The International comparison of Systems of care and patient outcomes In minor Stroke and Tia (InSIST) study: A community-based cohort study. International Journal of Stroke, 14(2), 186-190 doi:10.1177/1747493018799983

Krishnamurthi, R., Hale, L., Barker-Collo, S., Theadom, A., Bhattacharjee, R., George, A., Parmar, P., . . . Feigin, V. (2018). Mobile technology for primary stroke prevention. Stroke, 50, 196-198. doi:10.1161/STROKEAHA.118.023058

Theadom, A., Rodrigues, M., Poke, G., O’Grady, G., Love, D., Hammond-Tooke, G., Parmar, P., Baker, R., Feigin, V., Jones, K., Te Ao, B., Ranta A., & Roxburgh, R., on behalf of the MD-PREV Research group (2019). A nationwide, population-based prevalence study of genetic muscle disorders. Neuroepidemiology, 52, 128-135. doi: